[go: up one dir, main page]

ATE161578T1 - Heparinase gen von flavobacterium heparinum - Google Patents

Heparinase gen von flavobacterium heparinum

Info

Publication number
ATE161578T1
ATE161578T1 AT92923556T AT92923556T ATE161578T1 AT E161578 T1 ATE161578 T1 AT E161578T1 AT 92923556 T AT92923556 T AT 92923556T AT 92923556 T AT92923556 T AT 92923556T AT E161578 T1 ATE161578 T1 AT E161578T1
Authority
AT
Austria
Prior art keywords
gene
flavobacterium heparinum
heparinase
heparinase gene
orf
Prior art date
Application number
AT92923556T
Other languages
English (en)
Inventor
Ramnath Sasisekharan
Kelley Moremen
Charles L Cooney
Joseph J Zimmermann
Robert S Langer
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of ATE161578T1 publication Critical patent/ATE161578T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92923556T 1991-10-23 1992-10-22 Heparinase gen von flavobacterium heparinum ATE161578T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/783,706 US5714376A (en) 1991-10-23 1991-10-23 Heparinase gene from flavobacterium heparinum

Publications (1)

Publication Number Publication Date
ATE161578T1 true ATE161578T1 (de) 1998-01-15

Family

ID=25130160

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92923556T ATE161578T1 (de) 1991-10-23 1992-10-22 Heparinase gen von flavobacterium heparinum

Country Status (9)

Country Link
US (2) US5714376A (de)
EP (1) EP0610408B1 (de)
JP (2) JP3880062B2 (de)
AT (1) ATE161578T1 (de)
CA (1) CA2122004C (de)
DE (1) DE69223802T2 (de)
ES (1) ES2111653T3 (de)
GR (1) GR3026205T3 (de)
WO (1) WO1993008289A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681733A (en) * 1994-06-10 1997-10-28 Ibex Technologies Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium heparinum
EP0852491B1 (de) * 1995-09-29 2004-08-11 BioMarin Pharmaceutical Inc Verwendung von heparinasen zur verminderung von entzündungsreaktionen
US6217863B1 (en) 1995-10-30 2001-04-17 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from heparinase I
CA2341412A1 (en) * 1998-08-27 2000-03-09 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase i and ii
US7056504B1 (en) 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
US6235725B1 (en) 1998-10-30 2001-05-22 Baker Norton Pharmaceuticals, Inc. Methods and compositions for the prevention of tolerance to medications
CA2643162C (en) * 1999-04-23 2018-01-02 Massachusetts Institute Of Technology Polymer identification, compositional analysis and sequencing, based on property comparison
CA2402160C (en) * 2000-03-08 2012-02-14 Massachusetts Institute Of Technology Heparinase iii and uses thereof
CA2422059C (en) * 2000-09-12 2012-05-15 Massachusetts Institute Of Technology Methods and products related to low molecular weight heparin
EP1328260A2 (de) * 2000-10-18 2003-07-23 Massachusetts Institute Of Technology Verfahren und produkte zur pulmonalen verabreichung von polysacchariden
ATE481478T1 (de) * 2002-06-03 2010-10-15 Massachusetts Inst Technology Rationell konstruierte, von chondroitinase b abgeleitete lyasen
DE102005038418A1 (de) * 2005-08-12 2007-02-15 Dade Behring Marburg Gmbh Faktor Xa-basierter Heparinassay unter Verwendung einer Heparin-modifizierenden Komponente
US7691613B2 (en) * 2006-11-03 2010-04-06 Momenta Pharmaceuticals, Inc. Glycosaminoglycan lyase IV and uses thereof
US7691612B2 (en) * 2005-11-03 2010-04-06 Momenta Pharmaceuticals, Inc. Heparan sulfate glycosaminoglycan lyase and uses thereof
US7767420B2 (en) * 2005-11-03 2010-08-03 Momenta Pharmaceuticals, Inc. Heparan sulfate glycosaminoglycan lyase and uses thereof
CN103992995B (zh) * 2014-06-05 2016-05-04 山东大学 一种高表达水溶性肝素酶i融合蛋白及其编码基因
CN110343691B (zh) * 2019-07-24 2023-10-31 宝锐生物科技泰州有限公司 突变型肝素酶ⅰ及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54107584A (en) * 1978-02-10 1979-08-23 Seikagaku Kogyo Co Ltd Preparation of pure heparinase
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
IT1141249B (it) * 1980-02-28 1986-10-01 Italfarmaco Spa Procedimento per la preparazione di copolimeri di polisaccaridi supprotanti attivita' enzimatica,e copolimeri cosi' ottenuti
US4341869A (en) * 1980-08-25 1982-07-27 Massachusetts Institute Of Technology Process for producing heparinase
US4373023A (en) * 1980-10-14 1983-02-08 Massachusetts Institute Of Technology Process for neutralizing heparin
US4757012A (en) * 1983-06-28 1988-07-12 Genentech, Inc. Ascorbic acid intermediates and process enzymes
US4847338A (en) * 1985-03-28 1989-07-11 University Of Iowa Research Foundation Low molecular weight heparin fragments as inhibitors of complement activation
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
US4839293A (en) * 1986-02-24 1989-06-13 The Trustees Of Columbia University In The City Of New York DNA encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof
US4795703A (en) * 1986-03-07 1989-01-03 The Children's Medical Center Corporation Heparin assay
US4885207A (en) * 1987-07-13 1989-12-05 Uop Biocompatible protein or ligand immobilization system
WO1989012692A1 (en) * 1988-06-06 1989-12-28 Massachusetts Institute Of Technology Large scale method for purification of high purity heparinase
JP2833793B2 (ja) * 1989-09-19 1998-12-09 科学技術振興事業団 ヘパリナーゼをコードするプラスミド、このプラスミドを保持するヘパリナーゼ生産株及びヘパリナーゼの製造法

Also Published As

Publication number Publication date
CA2122004A1 (en) 1993-04-29
DE69223802D1 (de) 1998-02-05
DE69223802T2 (de) 1998-05-20
ES2111653T3 (es) 1998-03-16
US5830726A (en) 1998-11-03
GR3026205T3 (en) 1998-05-29
JP3880062B2 (ja) 2007-02-14
US5714376A (en) 1998-02-03
JPH07503608A (ja) 1995-04-20
EP0610408A1 (de) 1994-08-17
JP2004057201A (ja) 2004-02-26
WO1993008289A1 (en) 1993-04-29
CA2122004C (en) 2003-08-19
EP0610408B1 (de) 1997-12-29

Similar Documents

Publication Publication Date Title
ATE161578T1 (de) Heparinase gen von flavobacterium heparinum
IL80826A (en) Antigenic proteins from eimeria tenella,their production and their use in the prevention of coccidiosis
DK239383A (da) Mikrobiologisk fremstillede alfa- og beta-interferoner, dna-sekvenser, der koder for disse interferoner, mikroorganismer, som indeholder denne genetiske information, og fremgangsmaade til deres fremstilling
DK72593D0 (da) Rekombinant protein
DK0689592T3 (da) Stabile produkter af det baktericide/permeabilitetsforøgende protein og farmaceutiske sammensætninger, der indeholder disse
ATE184052T1 (de) Gdf-1 und uog1 proteine
PT1346034E (pt) Polipéptido da protease de clivagem do factor de von willebrand (vwf), ácido nucleico que codifica o polipéptido e utilização do polipéptido
DK0666914T3 (da) Hidtil ukendt P-selectin-ligandprotein
NZ527971A (en) Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon
DK0433117T3 (da) Nye polypeptider, DNA-sekvenser, som muliggør ekspression deraf, samt fremstilling og anvendelse deraf.
DK1127064T3 (da) Hidtil ukendte aminosyresekvenser, DNA, der koder for aminosyresekvenserme, antistoffer, der er rettet mod sådanne sekvenser, og forskellige anvendelser deraf
DK130290D0 (da) Lymfokiner, dna-sekvenser, som koder for disse lymfokiner og farmaceutiske midler indeholdende disse lymfokiner
TW342413B (en) Novel toxins isolated from Bracon Hebetor
WO1990000179A3 (fr) Nouvelles proteins, adn les codant et leur usage
ZA885915B (en) Acyl-peptide hydrolase and methods of production and use
NO178704C (no) DNA-sekvens som koder for protein med IRF-1-aktivitet, ekspresjonsvektor inneholdende denne, anvendelse av IRF-1 for å öke ekspresjon, vertscelle transformert med ekspresjonsvektoren, og protein med IRF-1-aktivitet
ATE301199T1 (de) Beta-primeverosidase gen
ATE398681T1 (de) Nukleotidsequenzen die für das mene-gen kodieren